Atrys Health, S.A. (BME:ATRY)
Spain
· Delayed Price · Currency is EUR 2.860
+0.010 (0.35%)
Apr 24, 2025, 12:57 PM CET
Atrys Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 218.1 | 206.1 | 163.2 | 123.85 | 33.81 | Upgrade
|
| Revenue Growth (YoY) | 5.82% | 26.28% | 31.77% | 266.34% | 102.95% | Upgrade
|
| Cost of Revenue | 162.17 | 148.96 | 116.26 | 89.67 | 21.41 | Upgrade
|
| Gross Profit | 55.92 | 57.15 | 46.95 | 34.19 | 12.4 | Upgrade
|
| Selling, General & Admin | 1.55 | 1.84 | 2.58 | 0.68 | 0.21 | Upgrade
|
| Other Operating Expenses | 23.41 | 27.21 | 29.15 | 16.75 | 3 | Upgrade
|
| Operating Expenses | 54 | 58.73 | 57.7 | 38.22 | 9.19 | Upgrade
|
| Operating Income | 1.92 | -1.58 | -10.75 | -4.03 | 3.21 | Upgrade
|
| Interest Expense | -23.48 | -33.05 | -14.53 | -11.03 | -2.35 | Upgrade
|
| Interest & Investment Income | 0.47 | 0.63 | 2.91 | 1.85 | 0.21 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.19 | -0.04 | -0.42 | -1.32 | -0.91 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.09 | 1.03 | -1.08 | 0.97 | -1.79 | Upgrade
|
| EBT Excluding Unusual Items | -15.2 | -33.01 | -23.88 | -13.57 | -1.63 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -11.3 | -3.76 | Upgrade
|
| Asset Writedown | -18.27 | -0.68 | -2.91 | -0.01 | - | Upgrade
|
| Pretax Income | -33.47 | -33.7 | -26.79 | -24.88 | -5.38 | Upgrade
|
| Income Tax Expense | -1.62 | -2.94 | -0.84 | -1.69 | 0.17 | Upgrade
|
| Earnings From Continuing Operations | -31.85 | -30.76 | -25.96 | -23.2 | -5.55 | Upgrade
|
| Earnings From Discontinued Operations | -0.16 | -15.14 | 2.55 | -0.05 | - | Upgrade
|
| Net Income to Company | -32.01 | -45.9 | -23.41 | -23.24 | -5.55 | Upgrade
|
| Minority Interest in Earnings | 0.23 | 0.31 | 0.26 | -0.01 | - | Upgrade
|
| Net Income | -31.77 | -45.59 | -23.15 | -23.26 | -5.55 | Upgrade
|
| Net Income to Common | -31.77 | -45.59 | -23.15 | -23.26 | -5.55 | Upgrade
|
| Shares Outstanding (Basic) | 76 | 76 | 68 | 50 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 76 | 68 | 50 | 28 | Upgrade
|
| Shares Change (YoY) | 0.16% | 11.15% | 35.64% | 77.58% | 31.93% | Upgrade
|
| EPS (Basic) | -0.42 | -0.60 | -0.34 | -0.46 | -0.20 | Upgrade
|
| EPS (Diluted) | -0.42 | -0.60 | -0.34 | -0.46 | -0.20 | Upgrade
|
| Free Cash Flow | -1.25 | -0.55 | -22.2 | 0.47 | -4.59 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.33 | 0.01 | -0.16 | Upgrade
|
| Gross Margin | 25.64% | 27.73% | 28.77% | 27.60% | 36.68% | Upgrade
|
| Operating Margin | 0.88% | -0.77% | -6.59% | -3.26% | 9.51% | Upgrade
|
| Profit Margin | -14.57% | -22.12% | -14.18% | -18.78% | -16.41% | Upgrade
|
| Free Cash Flow Margin | -0.57% | -0.27% | -13.60% | 0.38% | -13.58% | Upgrade
|
| EBITDA | 19.32 | 17.58 | 6.96 | 8.35 | 6.68 | Upgrade
|
| EBITDA Margin | 8.86% | 8.53% | 4.26% | 6.74% | 19.77% | Upgrade
|
| D&A For EBITDA | 17.4 | 19.16 | 17.71 | 12.39 | 3.47 | Upgrade
|
| EBIT | 1.92 | -1.58 | -10.75 | -4.03 | 3.21 | Upgrade
|
| EBIT Margin | 0.88% | -0.77% | -6.59% | -3.26% | 9.51% | Upgrade
|
| Revenue as Reported | 224.98 | 207 | 164.14 | 127.84 | 34.72 | Upgrade
|
| Advertising Expenses | 0.46 | 0.79 | 0.68 | 0.68 | 0.21 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.